争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 5 条
2026
CVS同意支付3.15亿美元解决阿片类药物处方案件
和解
CVS Pharmacy Inc.及其相关企业同意支付3.15亿美元，以解决有关阿片类药物及其他受管制药物处方，以及向联邦医疗保健项目提交索赔的指控。和解还包括一项与缉毒局达成的协议，要求CVS设立举报热线，并建立监测和处方医师审查流程。和解所解决的事项仅为指控，尚无责任认定。
品牌回应
整改 — CVS
In addition to the monetary payment announced today, CVS has entered into a memorandum of agreement with DEA to address its future obligations in dispensing controlled substances. This agreement requires CVS to establish a hotline for both employees and the public to report suspected illegal dispensing of controlled substances, proactively monitor the dispensing patterns of its pharmacies to identify and address potentially illegal dispensing, and establish a process to evaluate prescribers suspected of illegal prescribing.
来源摘录
In addition to the monetary payment announced today, CVS has entered into a memorandum of agreement with DEA to address its future obligations in dispensing controlled substances. This agreement requires CVS to establish a hotline for both employees and the public to report suspected illegal dispensing of controlled substances, proactively monitor the dispensing patterns of its pharmacies to identify and address potentially illegal dispensing, and establish a process to evaluate prescribers suspected of illegal prescribing.
US Attorney Ken Sorenson announced that CVS Pharmacy Inc. chain, and its related corporate entities have agreed to pay $315 million to resolve allegations in an opioid prescriptions and claims case.
The claims resolved by the settlement are allegations only, and there has been no determination of liability.
2021
诉讼称 CVS Health Peas 导致消费者受伤
提起诉讼
一名康涅狄格州居民起诉 CVS Pharmacy，称 CVS Health Peas 按说明微波后发生破裂，热内容物溢出并造成烧伤。诉状指称产品存在过失，且说明不足或具有误导性。这些是诉讼中的主张，并非法院认定。
来源摘录
The plaintiff believes that the defendant’s product was improperly or inadequately designed, manufactured, and or labeled.
On Wednesday, a Connecticut resident filed a lawsuit against CVS Pharmacy in the District of Connecticut, citing personal injury and loss of sensation after the use of CVS Health Peas, a therapeutic product sold by the pharmacy chain.
Upon removing the CVS Health Peas from the microwave, the complaint said, the plastic casing of the product suddenly, and without warning, ruptured and the heated contents were caused to spill out onto the plaintiff.
2019
CVS药房暂停销售Zantac及雷尼替丁产品
整改
CVS Pharmacy表示，已暂停销售Zantac品牌和CVS Health品牌的雷尼替丁产品，直至另行通知。此次暂停销售是在FDA警告雷尼替丁产品可能含有潜在人类致癌物之后作出的。报道指出，这些产品当时并未被召回，FDA也未建议患者停止服用。
CVS Pharmacy表示，在FDA警告雷尼替丁产品可能含有潜在人类致癌物后，暂停销售Zantac品牌和CVS Health品牌的雷尼替丁产品，暂停时间另行通知。报道指出，这些产品当时并未被召回，FDA也未建议患者停止服用。
来源摘录
CVS Pharmacy announced Saturday that it has suspended the sale of all Zantac brand and CVS Health-brand ranitidine products until further notice
The announcement comes in response to an alert from the FDA that ranitidine products may contain a possible human carcinogen and cause cancer.
While Zantac and ranitidine products have not been recalled, and the FDA is not recommending patients stop taking these products, customers can still return the products to CVS for a refund.
2019
加州宣布对CVS Pharmacy采取360万美元执法行动
罚款或处罚
加州回收机构CalRecycle宣布对CVS Pharmacy采取360万美元执法行动，指称该州848家门店中的81家未为可回收瓶罐提供加州回收价值退款。
来源摘录
CalRecycle accuses 81 of the pharmacy's 848 retail stores statewide of failing to offer California Redemption Value (CRV) for recyclable bottles and cans.
The state agency CalRecycle announced Monday an enforcement action against CVS Pharmacy for $3.6 million.
2013